CC2D2A, coiled-coil and C2 domain containing 2A, 57545
N. diseases: 167; N. variants: 93
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
4 | 15601446 | 3 prime UTR variant | G/C;T | snv | 0.58; 9.4E-06 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||||
|
0.882 | 0.160 | 4 | 15557452 | missense variant | G/A;C;T | snv | 1.7E-04; 4.1E-06; 1.2E-05 |
|
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 4 | 15557452 | missense variant | G/A;C;T | snv | 1.7E-04; 4.1E-06; 1.2E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 4 | 15557452 | missense variant | G/A;C;T | snv | 1.7E-04; 4.1E-06; 1.2E-05 |
|
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
4 | 15601446 | 3 prime UTR variant | G/C;T | snv | 0.58; 9.4E-06 |
|
0.700 | 1.000 | 2 | 2016 | 2018 | ||||||||||
|
4 | 15599527 | splice acceptor variant | A/G | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 6 | 2009 | 2017 | ||||||||||
|
1.000 | 0.160 | 4 | 15587843 | inframe deletion | GAA/- | delins | 4.0E-06 | 7.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 6 | 2009 | 2017 | ||||||
|
1.000 | 0.040 | 4 | 15593275 | intron variant | T/C | snv | 0.16 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15564135 | non coding transcript exon variant | C/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 4 | 15555819 | intron variant | C/A | snv | 0.14 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15562415 | intron variant | A/C | snv | 0.14 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15548155 | intron variant | G/A | snv | 5.7E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15550495 | intron variant | G/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 4 | 15559630 | intron variant | A/G | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15546688 | intron variant | C/T | snv | 0.12 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15560390 | intron variant | C/T | snv | 8.9E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15550575 | intron variant | T/C | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15550672 | intron variant | A/G | snv | 0.13 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15550800 | non coding transcript exon variant | C/T | snv | 0.13 | 0.14 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.040 | 4 | 15563585 | intron variant | T/C | snv | 0.14 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15556563 | intron variant | C/T | snv | 0.14 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15574641 | intron variant | A/G | snv | 0.55 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 15587691 | intron variant | C/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 4 | 15559008 | intron variant | C/G | snv | 0.41 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
4 | 15591241 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 |